These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10369627)

  • 1. Chlamydia pneumoniae and coronary heart disease.
    Carlisle SS; Nahata MC
    Ann Pharmacother; 1999 May; 33(5):615-22. PubMed ID: 10369627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae and vascular disease.
    Gibbs RG; Carey N; Davies AH
    Br J Surg; 1998 Sep; 85(9):1191-7. PubMed ID: 9752857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae.
    Cheng JW; Rivera NG
    Ann Pharmacother; 1998 Dec; 32(12):1310-6. PubMed ID: 9876813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease.
    Behbahani R; Verme-Gibboney C; Romanelli AM
    Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for coronary heart disease: The myth and the reality.
    Kuppuswamy VC; Gupta S
    Drugs Today (Barc); 2005 Oct; 41(10):677-85. PubMed ID: 16389410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia).
    Anderson JL; Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S569-71. PubMed ID: 10839761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae infection and coronary heart disease. Trials should assess whether antibiotics eliminate organism from atherosclerotic lesions.
    Taylor-Robinson D
    BMJ; 1997 Dec; 315(7121):1538. PubMed ID: 9420501
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlamydia pneumoniae infection in Slovenian patients with diffuse coronary artery disease.
    Zorc M; Kese D; Petrovic D; Legan M
    Med Arh; 2004; 58(6):331-4. PubMed ID: 15648226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.